Jiameng Zhang

Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double‐blind placebo‐controlled multicenter trial

Kathleen Hawker, Paul O’Connor, Mark S. Freedman et al. · Annals of Neurology · 2009 · 939 citations

Life Sciences, Neurology, Pharmacotherapy +15

Long-term Outcomes of Ranibizumab Therapy for Diabetic Macular Edema: The 36-Month Results from Two Phase III Trials

David M. Brown, Quan Dong Nguyen, Dennis M. Marcus et al. · Ophthalmology · 2013 · 821 citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +17

Abnormal B‐cell cytokine responses a trigger of T‐cell–mediated disease in MS?

Amit Bar‐Or, Lama Fawaz, Boli Fan et al. · Annals of Neurology · 2009 · 517 citations

Life Sciences, Immunology, Pharmacokinetics +17

Switching to a Protease Inhibitor-Containing, Nucleoside-Sparing Regimen (Lopinavir/Ritonavir Plus Efavirenz) Increases Limb Fat But Raises Serum Lipid Levels

Pablo Tebas, Jiameng Zhang, Kevin E. Yarasheski et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2007 · 59 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacotherapy +17

Neurological evaluation of untreated human immunodeficiency virus infected adults in Ethiopia

David B. Clifford, Mesfin Teshome Mitike, Yared Mekonnen et al. · Journal of NeuroVirology · 2007 · 51 citations

Medicine, Infectious Diseases, Neurology +9